Related Experiment Video

Updated: Jun 6, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
08:37

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice

Published on: April 21, 2015

Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel disease

R Hontecillas1, W T Horne, M Climent

  • 1CyberInfrastructure Division, Virginia Bioinformatics Institute, Virginia Polytechnic Institute and State University, Blacksburg, Virginia, USA.

Mucosal Immunology
|November 12, 2010
PubMed

Insights

Macrophages expressing PPAR-γ are crucial for managing inflammatory bowel disease (IBD). Targeting macrophage PPAR-γ (peroxisome proliferator-activated receptor-γ) offers a promising therapeutic strategy for IBD treatment.

Area of Science:

  • Immunology
  • Gastroenterology
  • Molecular Biology

Background:

  • Peroxisome proliferator-activated receptor-γ (PPAR-γ) is expressed in macrophages and is a potential therapeutic target for inflammatory bowel disease (IBD).
  • Computational studies highlight macrophages as critical targets for IBD therapies.

Purpose of the Study:

  • To investigate the mechanisms behind the therapeutic benefits of macrophage PPAR-γ in IBD.
  • To elucidate the role of macrophage PPAR-γ in regulating immune responses and disease progression in IBD.

Main Methods:

  • Macrophage-specific deletion of PPAR-γ in a mouse model of IBD.
  • Analysis of clinical disease activity, colonic pathology, and immune cell populations (T cells, macrophages).
  • Assessment of gene and protein expression in colonic tissues and immune cells.

Main Results:

  • Macrophage-specific PPAR-γ deletion worsened IBD severity, colonic pathology, and regulatory T-cell function.
  • Deletion increased pro-inflammatory markers, CD8+ T cells, and specific macrophage surface markers (CD40, Ly6C, TLR-4).
  • Macrophage PPAR-γ was essential for pioglitazone-induced recovery in dextran sodium sulfate (DSS) colitis.

Conclusions:

  • Macrophage PPAR-γ plays a critical protective role in IBD pathogenesis.
  • Targeting macrophage PPAR-γ with agonists represents a viable therapeutic approach for IBD.
  • PPAR-γ in macrophages is a key cellular target for anti-inflammatory effects in IBD treatment.

More Related Videos

Depletion and Reconstitution of Macrophages in Mice08:50

Depletion and Reconstitution of Macrophages in Mice

Published on: August 1, 2012

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...